Senseonics Holdings (SENS) COO Mukul Jain Sells 40,000 Shares

Share on StockTwits

Senseonics Holdings (NYSEAMERICAN:SENS) COO Mukul Jain sold 40,000 shares of the business’s stock in a transaction dated Tuesday, June 19th. The shares were sold at an average price of $4.50, for a total value of $180,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Mukul Jain also recently made the following trade(s):

  • On Monday, April 9th, Mukul Jain sold 15,706 shares of Senseonics stock. The shares were sold at an average price of $3.85, for a total value of $60,468.10.
  • On Friday, April 6th, Mukul Jain sold 24,294 shares of Senseonics stock. The shares were sold at an average price of $3.75, for a total value of $91,102.50.
  • On Monday, April 2nd, Mukul Jain sold 27,437 shares of Senseonics stock. The shares were sold at an average price of $3.25, for a total value of $89,170.25.

SENS traded down $0.31 during midday trading on Friday, reaching $4.67. 495,952 shares of the company were exchanged, compared to its average volume of 944,080. The company has a debt-to-equity ratio of 0.76, a current ratio of 2.93 and a quick ratio of 2.81. Senseonics Holdings has a one year low of $1.68 and a one year high of $5.25.

Senseonics (NYSEAMERICAN:SENS) last announced its earnings results on Thursday, May 10th. The company reported ($0.16) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.04). Senseonics had a negative return on equity of 406.72% and a negative net margin of 828.76%. The business had revenue of $2.90 million during the quarter, compared to analysts’ expectations of $2.59 million. The business’s revenue was up 480.0% on a year-over-year basis. equities analysts anticipate that Senseonics Holdings will post -0.54 earnings per share for the current year.

Hedge funds and other institutional investors have recently made changes to their positions in the company. BlueCrest Capital Management Ltd purchased a new position in shares of Senseonics in the 4th quarter worth approximately $198,000. Perceptive Advisors LLC boosted its stake in shares of Senseonics by 130.0% in the 4th quarter. Perceptive Advisors LLC now owns 115,000 shares of the company’s stock worth $306,000 after buying an additional 65,000 shares during the last quarter. California State Teachers Retirement System purchased a new position in shares of Senseonics in the 4th quarter worth approximately $651,000. Millennium Management LLC boosted its stake in shares of Senseonics by 15.3% in the 4th quarter. Millennium Management LLC now owns 967,208 shares of the company’s stock worth $2,573,000 after buying an additional 128,658 shares during the last quarter. Finally, Raymond James Financial Services Advisors Inc. boosted its stake in shares of Senseonics by 38.9% in the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 487,175 shares of the company’s stock worth $1,296,000 after buying an additional 136,425 shares during the last quarter. Hedge funds and other institutional investors own 30.66% of the company’s stock.

A number of brokerages have commented on SENS. Canaccord Genuity reissued a “buy” rating on shares of Senseonics in a report on Friday, March 2nd. Raymond James boosted their price objective on Senseonics from $4.00 to $6.00 and gave the stock an “outperform” rating in a report on Friday. BTIG Research reissued a “buy” rating and set a $5.00 price objective on shares of Senseonics in a report on Thursday, June 7th. Guggenheim began coverage on Senseonics in a report on Tuesday, April 3rd. They set a “buy” rating and a $6.00 price objective for the company. Finally, Craig Hallum began coverage on Senseonics in a report on Monday, June 11th. They set a “buy” rating and a $7.00 price objective for the company. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $5.80.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days.

Insider Buying and Selling by Quarter for Senseonics (NYSEAMERICAN:SENS)

Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply